Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping

Objectives The purpose of this study was to investigate a noninvasive method for quantifying diffuse myocardial fibrosis with cardiac magnetic resonance imaging (CMRI). Background Diffuse myocardial fibrosis is a fundamental process in pathologic remodeling in cardiomyopathy and is postulated to cau...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2008-11, Vol.52 (19), p.1574-1580
Main Authors: Iles, Leah, MBChB, Pfluger, Heinz, MD, Phrommintikul, Arintaya, MD, Cherayath, Joshi, Dip AMIT, Aksit, Pelin, MS, Gupta, Sandeep N., PhD, Kaye, David M., PhD, Taylor, Andrew J., PhD
Format: Article
Language:English
Subjects:
Acquisitions & mergers
Adult
Analysis of Variance
Body Surface Potential Mapping
cardiac magnetic resonance imaging
Cardiology
Cardiomyopathy
Cardiovascular
Case-Control Studies
Collagen
Drug therapy
Female
fibrosis
Fibrosis - diagnosis
Gadolinium DTPA
Heart attacks
Heart failure
Heart Failure - diagnosis
Heart Failure, Diastolic - diagnosis
Heart Failure, Systolic - diagnosis
Heart rate
Humans
Image Enhancement - methods
Image Processing, Computer-Assisted
Internal Medicine
Magnetic Resonance Imaging - methods
Male
Middle Aged
Mortality
Musculoskeletal system
Myocardium - pathology
Patients
Probability
Prospective Studies
Reference Values
Severity of Illness Index
Studies
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives The purpose of this study was to investigate a noninvasive method for quantifying diffuse myocardial fibrosis with cardiac magnetic resonance imaging (CMRI). Background Diffuse myocardial fibrosis is a fundamental process in pathologic remodeling in cardiomyopathy and is postulated to cause increased cardiac stiffness and poor clinical outcomes. Although regional fibrosis is easily imaged with cardiac magnetic resonance, there is currently no noninvasive method for quantifying diffuse myocardial fibrosis. Methods We performed CMRI on 45 subjects (25 patients with heart failure, 20 control patients), on a clinical 1.5-T CMRI scanner. A prototype T1 mapping sequence was used to calculate the post-contrast myocardial T1 time as an index of diffuse fibrosis; regional fibrosis was identified by delayed contrast enhancement. Regional and global systolic function was assessed by cine CMRI in standard short- and long-axis planes, with echocardiography used to evaluate diastology. An additional 9 subjects underwent CMRI and endomyocardial biopsy for histologic correlation. Results Post-contrast myocardial T1 times correlated histologically with fibrosis (R = −0.7, p = 0.03) and were shorter in heart failure subjects than controls (383 ± 17 ms vs. 564 ± 23 ms, p < 0.0001). The T1 time of heart failure myocardium was shorter than that in controls even when excluding areas of regional fibrosis (429 ± 22 ms vs. 564 ± 23 ms, p < 0.0001). The post-contrast myocardial T1 time shortened as diastolic function worsened (562 ± 24 ms in normal diastolic function vs. 423 ± 33 ms in impaired diastolic function vs. 368 ± 20 ms in restrictive function, p < 0.001). Conclusions Contrast-enhanced CMRI T1 mapping identifies changes in myocardial T1 times in heart failure, which appear to reflect diffuse fibrosis.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2008.06.049